Pasteurella pneumotropica is an opportunistic pathogen in rodents. Natural infection in immunodeficient animals suggests that immunodeficiency is a major factor in P. pneumotropica pathogenesis. To understand this process, we performed clinical, pathological and bacteriological studies of immunodeficient NOD/ShiJic-scid/Jcl and immunocompetent Crlj:CD1 (ICR) mice experimentally infected with P. pneumotropica ATCC 35149. From 14 days postinoculation, some of P. pneumotropica-infected NOD/ShiJic-scid/Jcl mice developed clinical signs of weight loss. Three of 10 P. pneumotropica-infected NOD/ShiJic-scid/Jcl mice developed clinical signs of depression, ruffled coat, and weight loss and died at 27, 34, and 59 days postinoculation. At 35 days postinoculation, almost all P. pneumotropica-infected NOD/ShiJic-scid/Jcl mice had lung abscesses. The bacteria were isolated from the upper and lower respiratory tracts, including the lungs, and blood. In contrast, P. pneumotropicainfected ICR mice exhibited no clinical signs or lesions. The bacteria were isolated from the upper, but not the lower respiratory tracts. We developed an animal model for understanding host interactions with P. pneumotropica.
Introduction
Pasteurella pneumotropica is a Gram-negative, nonmotile coccobacillus that ferments carbohydrates such as glucose, producing acids, but not gas. The organism has 2 biovars, Jawetz and Heyl, which are regarded as 2 distinct species based on the molecular data. Antigenic differences have been demonstrated between mouse and rat strains [18] , but serotypes have not yet been established. Based on 16S rDNA sequence analysis, the Pasteurellaceae are divided into 21 phylogenetic clusters; P. pneumotropica belongs to the rodent cluster but not to Pasteurella sensu stricto [7] .
P. pneumotropica infection is ubiquitous in colonies -Original-of mice, rats, and other rodents. P. pneumotropica typically colonizes the upper respiratory tract, conjunctiva, intestines, and reproductive tissues [15] . In immunocompetent animals, clinical signs are not commonly observed. However, immunodeficient animals infected with P. pneumotropica develop mild to severe or lethal disease [1, 5, 9, 13, 16, 17] . Athymic nude mice (nu/nu) develop abscesses, notably in the orbital and preputial regions [16] . Nude rats (rnu/rnu) also develop conjunctivitis and periorbital abscesses [17] . In Cd28-deficient mice, orbital abscesses have occurred [1] . Mice with targeted deletion of the JH region of the immunoglobulin heavy chain have a high incidence of fatal pneumonia [13] . Mice lacking functional alleles at MHCII, Tlr4 (toll-like receptor 4), and Nramp 1 genes [5, 9] contracted pneumonia and died. In experimental infection, a little work has been done to investigate the pathogenicity of P. pneumotropica. Furthermore, to our knowledge, study of experimental infection with the bacteria in NOD/ShiJic-scid/Jcl mice has not been reported. We attempted to demonstrate the importance of immunodeficiency in P. pneumotropica pathogenicity in mice. Immunodeficient NOD/ShiJic-scid/Jcl with adaptive and nonadaptive immunologic function and immunocompetent Crlj:CD1 (ICR) mice were inoculated intranasally with P. pneumotropica and studied clinically, pathologically, and bacteriologically. Our data indicate the immunologic basis for P. pneumotropica pathogenicity in mice.
Materials and Methods

Animals
Four-to five-week-old female NOD/ShiJic-scid/Jcl and Crlj:CD1 (ICR) mice were obtained from CLEA, Japan, Inc., Tokyo, Japan, and Charles River Japan, Inc., Kanagawa, Japan. Mice were housed on sterilized spruce bedding (White Flakes, Oriental Yeast Co., Ltd., Tokyo, Japan) in sterilized cages (Clean S TPX cage, CLEA Japan, Inc.) within a laminar air flow cabinet (Okazaki Sangyo Co., Ltd., Tokyo, Japan). The animals were fed sterilized standard pelletized chow (FR-1, Funabashi Farm Co., Ltd., Chiba, Japan), and water was available ad libitum in water bottles. The animal room was maintained at 24 ± 2°C and 50 ± 10% relative humidity with a 12:12-h light:dark cycle. NOD/ShiJic-scid/Jcl mice were free of Mycoplasma pulmonis, Corynebacterium kutscheri, Pasteurella pneumotropica, Pseudomonas aeruginosa, and Salmonella spp. based on bacterial cultures and free of ectoparasites, intestinal protozoa, and pinworms based on parasitologic examination. In addition, the ICR mice were free of Sendai virus, mouse hepatitis virus, and Clostridium piliforme based on serologic test. All mice were between 5 and 6 weeks old when first infected with P. pneumotropica. The mice were observed for 70 days. Preliminary experiments for 14 days suggested that it was not acute infection. Because of our first experimental infection with P. pneumotropica of NOD/ShiJic-scid/Jcl mice, we chose the death of animals for humane endpoints. All animal experimental procedures were approved by the Animal Experiment Committee of Tokyo Medical University, and animal care was in accordance with the Guideline for Animal Experimentation established by the Japanese Association for Laboratory Animal Science.
Preparation of P. pneumotropica inoculum
Pasteurella pneumotropica strain ATCC 35149 (type Jawetz) isolated from mice was used to prepare the inoculum. The strain possessed the outermost surface materials on the bacterial cells [11] and was identified as a-1 by amplified 16S ribosomal DNA restriction analysis [20] . The strain was thawed from frozen stock (-80°C) and grown overnight on 5% horse blood agar plates (Climedia, Sankyo Junyaku Co., Ltd., Tokyo, Japan) and checked for purity. The organism was cultured in brain heart infusion (BHI) broth (Eiken Chemical Co., Ltd., Tokyo, Japan) at 37°C for 24 h.
Experimental infection
Twenty NOD/ShiJic-scid/Jcl and 20 ICR mice were divided into 6 groups and treated as follows: group I (15 NOD/ShiJic-scid/Jcl mice), P. pneumotropica inoculated; group II (15 ICR mice), P. pneumotropica inoculated; group III (3 NOD/ShiJic-scid/Jcl mice), shaminoculated with BHI broth; group IV (3 ICR mice), sham-inoculated with BHI broth; group V (2 NOD/ ShiJic-scid/Jcl mice), untreated; and group VI (2 ICR mice), untreated. Groups I and II mice were inoculated intranasally with P. pneumotropica at a dose of 10 7 CFU in 25 µl BHI broth using a micropipette. Group III and IV mice received 25 µl BHI broth intranasally. Five mice from groups I and II and 1 each from groups III and IV were euthanized by cervical dislocation 7, 35, and 70 days postinoculation, and 1 mouse each from groups V and VI was euthanized in the same manner 35 and 70 days postinoculation. Each mouse was examined clinically, pathologically, and bacteriologically. Deceased mice were examined in a similar way as described above.
Pathological examination
All animals were examined for gross and microscopic lesions on the day of death. After gross examination, the trachea, lungs, heart, liver, spleen, kidneys, adrenal glands, pancreas, esophagus, stomach, duodenum, and small and large intestine were aseptically removed. The tissue specimens were fixed in 10% neutral buffered formalin, embedded in paraffin, and sectioned at a thickness of 5 µm. Sections were stained with hematoxylin and eosin using standard procedures and examined for microscopic lesions.
Bacteriologic examination
At necropsy, specimens from the nasal cavity, conjunctiva, oral cavity, oropharynx, trachea, lungs, and heart blood were streaked onto horse blood agar plates and incubated at 37°C for 24-48 h. Bacterial identification as P. pneumotropica included the following criteria: Gram-negative coccobacillus; positive results for glucose, ornithine decarboxylase, urease, nitrate reductase, indole production, catalase, oxidase, and b-galactosidase; and negative results for motility, H 2 S production, and citrate utilization.
Results
Clinical signs
At 7 days postinoculation, all groups of mice appeared to be normal. Wasting death of 3 mice from group I occurred spontaneously at 27, 34, and 59 days postinoculation. At 35 days postinoculation, 3 out of 8 P. pneumotropica-infected NOD/ShiJic-scid/Jcl mice of group I showed clinical signs (depression, ruffled coat, and weight loss) of wasting disease. At 70 days postinoculation, 1 out of 3 mice in group I showed weight loss. The motility of the mice in this group was 20%. In contrast, no clinical signs were observed in the group II P. pneumotropica-infected ICR mice and uninfected control mice in groups III, IV, V, and VI.
Pathology
At 7 days postinoculation, no mice exhibited gross lesions. At 35 days postinoculation, 4 out of 6 P. pneumotropica-infected NOD/ShiJic-scid/Jcl mice (group I) had gross lesions consistent with pneumonia. At 70 days postinoculation, 3 out of 4 mice in group I had gross lesions consisting of lung abscesses (Fig. 1A : mild case). The animal that died at 59 days postinoculation had the most severe lung lesions (Fig. 1B: severe case). Most of the right lobes of the lung were abscessed. The pressure of the abscesses caused atrophy of the left lobes. In contrast, the P. pneumotropica-infected ICR mice in group II had no gross lesions. The remaining sham-inoculated and untreated control mice (from groups III to VI) were grossly normal. Table 1 shows the histological findings for the P. pneumotropica-infected NOD/ShiJic-scid/Jcl and ICR mice. P. pneumotropica-infected NOD/ShiJic-scid/Jcl mice (group I) had no lesions at 7 days postinfection. At 35 and 70 days postinoculation, 8 out of 10 mice in group I had lung abscesses. In the severe case, marked degeneration and neutrophil infiltration were seen ( Fig.  2A) . The infiltration and exudate disrupted the alveolar structure. In the mild case, foal abscesses were observed (Fig. 2B) . Sham-inoculated and untreated control NOD/ ShiJic-scid/Jcl mice had no lesions in the lungs (Fig. 2C  and 2D ). Lesions were absent in the other tested organs. Lesions were not observed in P. pneumotropica-infected ICR mice (group II) or in the remaining animals (groups III, IV, V, and VI).
Pasteurella pneumotropica isolation
On the basis of preliminary experiments findings, the nasal cavity, conjunctiva, oral cavity, pharyngolarynx, trachea, lung, and heart blood were cultured to establish colonization patterns of P. pneumotropica in NOD/ ShiJic-scid/Jcl and ICR mice. The bacteria were isolated variously from the nasal cavity, conjunctiva, oral cavity, and pharyngolarynx of P. pneumotropica-infected NOD/ShiJic-scid/Jcl (group I) and ICR (group II) mice ( Table 2) . P. pneumotropica was isolated variously from the trachea, lung, and blood in group I but not group II. In group I, the prevalence of P. pneumotropica in the pharyngolarynx and lung was 100%. The isolation rate of P. pneumotropica in trachea increased with increasing postinoculation days, and was 100% at 70 days postinoculation. In contrast, the isolation rate of the bacteria in nasal cavities and conjunctiva was reduced over time. P. pneumotropica was isolated from blood in mice at 35 days postinoculation, but not at 7 and 70 days. In group II, the prevalence of P. pneumotropica in the oral cavity and pharyngolarynx was higher than in the nasal cavity and conjunctiva. The bacteria was never isolated from uninfected control mice in groups III, IV, V, and VI. 
Discussion
We have experimentally demonstrated that Pasteurella pneumotropica is pathogenic in immunodeficient animals, but not in immunocompetent animals. This conclusion is based on the finding that P. pneumotropica causes pulmonary lesions and death in immunodeficient NOD/ShiJicscid/Jcl mice, but not in immunocompetent ICR mice. Furthermore, this study developed an animal model for understanding host-P. pneumotropica interactions. Two dead mice were not tested. c) One dead mouse were not tested.
In natural infection of P. pneumotropica, several investigations have demonstrated that immunodeficient animals develop moderate to serious disease. Athymic nude mice and rats suffer from abscesses and conjunctivitis [16, 17] . B cell-deficient mice, in which the JH region of the immunoglobulin heavy chain is deleted, have a high incidence of fatal pneumonia [13] . Furthermore, orbital abscesses occurred in STOCK-cd28 tm1Mak mice in which cd28 expression is disrupted [1] . However, there is little information available on pathogenicity in experimental infection models. Chapes reported that mice with nonfunctional alleles at MHCII, Tlr4, and Nramp 1 developed severe pneumonia [5] . Our study experimentally demonstrated that P. pneumotropica is pathogenic in immunodeficient NOD/ShiJic-scid/Jcl mice, but not in immunocompetent ICR mice. Excepting NOD/ShiJic-scid/Jcl mice, there are a variety of immunodeficient mice such as Rag-2 and cytokine KO mice. The pathogenicity of P. pneumotropica for various immunodeficient mice is deeply interesting.
The SCID mice [4] , which are deficient in immune functions mediated by T and B lymphocytes, are used widely in biological and medical research. NOD mice are characterized by a functional deficit in NK cells, absence of circulating complement, and deficient function of antigen-presenting cells including macrophages. We used NOD/ShiJic-scid/Jcl mice in this study. The mice have multiple defects in adaptive and nonadaptive immunologic function [23] . Our study demonstrated that NOD/ShiJic-scid/Jcl mice are highly susceptible to P. pneumotropica. In T cell-deficient mice [16] , the lesions were limited and consisted of abscesses notably in orbital and preputial regions. In B cell-deficient mice infected with P. pneumotropica and Pneumocystis carinii [13] , the mice had gross changes in the lungs, which consisted of foci of suppurative consolidation. This suggested the possibility of an indirect role of P. carinii in clinical disease. Mice with nonfunctional T cell-and TLR 4-positive macrophages demonstrated severe, and sometimes fatal, pneumonia [5, 9] . The mice had gross lesions consisting of large, multifocal to coalescing abscesses [5] . Although TLR-4 macrophage-deficient mice developed pneumonia, the pneumonia did not progress. Fatal pneumonia occurred only when both T cells and TLR-4 were nonfunctional. Our study demonstrated that NOD/ShiJic-scid/Jcl mice, which are deficient in immune functions mediated by T and B cells and functions of macrophages, have the most severe lung abscess lesions (Fig. 1B) compared with the results of previous studies in regard to the size of lesions. These results demonstrated that the degree of lesions was due to the grade of deficiency in immune function. The relation between the lung lesions of NOD/ShiJic-scid/Jcl mice and functions of T cell, B cell, and macrophages remains unclear.
We observed that P. pneumotropica were isolated only from upper respiratory tract in infected ICR mice. In NOD/ShiJic-scid/Jcl mice, however, the bacteria were isolated from the upper and lower respiratory tracts. The bacteria was isolated from lungs of all the infected NOD/ ShiJic-scid/Jcl mice, and 8 out of 10 mice had mild to severe lung abscess lesions. The lower resistance of the mouse in the upper respiratory tract is probably mediated by innate (nonadaptive) and adaptive immunity [2] . The lung lesions in NOD/ShiJic-scid/Jcl mice may be the result of rapid growth of the bacteria in the upper respiratory tract due to the defects in adaptive and nonadaptive immunological functions. When a critical number of bacteria is exceeded, the bacteria may be able to invade the lower respiratory tract and cause lung abscess lesions. The severity of lung abscess lesions may correlate with the number of P. pneumotropica cells in the lung [5, 12, 24] .
Pasteurella pneumotropica does not have cell surface structures, such as fimbriae, pili, and capsules [7, 10, 14] . However, Boot et al. [3] showed thin fimbriae by using negative staining and electron microscopy. Using transmission electron microscopy, we recently revealed the outer structure of the cell wall of P. pneumotropica [11] . Based on its biochemical characteristics, P. pneumotropica is classified as biovars Jawetz or Heyl. Based on restriction analysis of 16S ribosomal DNA, we divided P. pneumotropica into 4 groups, a-1, a-2, a-3, and a-4 [20] . Data from principal component analysis of biochemical and genetic characteristics were used to discriminate 3 host-dependent and host-independent groups [22] . P. pneumotropica strain ATCC 35149, which was used in this study, has cell surface structures and was classified as biovar Jawetz, genotype a-1, in the host-independent group. The relationship between dif-ferent characteristics of P. pneumotropica and its pathogenicity to animals is an intriguing problem.
Bacteria have a number of common pathogenic strategies. These include adherence to and colonization of host cell surfaces, invasion of host cells, production of substances that are toxic to host cells, and machinery for secretion of virulence factors [6] . A variety of virulence factors, such as pili, capsules, exotoxins, and endotoxins participate in microbial pathogenicity. In the field of medical and veterinary microbiology, bacterial virulence factors have been well studied [8] . However, the virulence factors of bacterial infection in laboratory animals have not been thoroughly studied. Recently, we described the identification and characterization of the RTX toxins [19, 21] . The P. pneumotropica animal model developed in this study will be useful for investigating virulence factors such as RTX toxin.
In conclusion, P. pneumotropica is pathogenic in immunodeficient NOD/ShiJic-scid/Jcl mice. Further work is needed to investigate the interaction between P. pneumotropica virulence factors and the host (NOD/ShiJicscid/Jcl mice).
